Insulet(PODD)
Focus: Insulet is a public medical device company headquartered in Massachusetts that designs and manufactures the Omnipod insulin pump system for diabetes management. The company generates $1.7B in annual revenue with a focused market position in automated glucose control.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Employees
201-500
Open Jobs
215+24 this month
Hot — 196 jobs added in 30d
Net +24 (196 new, 172 removed). Aggressive expansion phase.
Should You Work at Insulet?
AI assessmentBest fit for commercial and manufacturing professionals seeking growth-stage device company exposure; R&D candidates should assess comfort with incremental innovation cycle.
Why Work Here
- Strong commercial momentum with 31% YoY revenue growth (FY2025: $1.7B vs FY2024: $1.3B) and return to profitability ($206M net income in FY2025)
- Aggressive hiring across 180 open roles, with heavy investment in Commercial (52 roles) and Engineering (35 roles) signaling market expansion
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$1.7B
Pipeline & Clinical Trials
Omnipod 5
DiabetesClinical Trials (1)
NCT07039942French Prospective Multicentric Study in Real World
N/AHelp build intelligence for Insulet
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.